Diagnostic Testing of STDs Market Analysis
Sexually transmitted disorders (STDs) are spread mainly by one-to-one sexual contact. Early detection or diagnosis of STDs and partner notifications can help prevent further spread.
Global Diagnostic Testing of STDs Market: Drivers
The rising rate of STDs will lead to an increase in the global diagnostic testing of STDs market within the estimated period. For example, as per the 2019 fact sheet of the UNAIDS Global HIV & AIDS statistics, 37.9 Mn people worldwide were HIV infected.
Furthermore, increasing funding for the treatment and management of STDs is likely to contribute to market growth. For example, the U.S. government released its fiscal year 2021 federal budget proposal in February 2020, which included US$ 716 Mn for the second year of the multi-year EHE enterprise to eradicate the HIV epidemic in the United States.
In 2019, Asia Pacific led the global diagnostic test of STDs market considering 36.3% of the value, then North America and Europe.
𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/3917
The size of the global diagnostic testing of STDs market was estimated to be accounted at US$ 140,028.5 Million and over the estimated period (2020-2027) it is likely to witness a value of US$ 290,128.2 Million with a CAGR of 9.6%.
Global Diagnostic Testing of STDs Market: Restraints
The stigma related to voluntary/client-initiated counselling and testing (CICT) STD testing is likely to obstruct market growth. Many laboratories or STD clinics avoid voluntary / CICT STD testing to avoid uneasy condition or complications in the community. This obstructs the taking of diagnostic tests or test volumes, thus obstructing market growth.
Furthermore, a tight regulatory situation is also likely to limit market growth. Diagnostic testing equipment for STDs can be commodified with a CE mark that can be aquired by following the in vitro diagnostic medical equipment, 98/79/EC and CLIA waiver guidelines in Europe. Other regions accept CE mark or USFDA approval.
Global Diagnostic Testing of STDs Market: Opportunities
The Research and Development STDs in the HIV auto-test kit are likely to provide beneficial growth opportunities for market players. For example, researchers at St. Michael’s Hospital, Canada’s Center for Urban Health Solutions, began clinical trials on an HIV auto-test kit aimed at obtaining official approval in August 2019, for the first such equipment in Canada.
Furthermore, the growing sexually transmitted infections is likely to help market growth. For example, according to provincial and regional government data compiled in 2019, more than 126,700 chlamydia infections and 28,300 gonorrhoea were diagnosed in Canada in 2017.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/3917
Global Diagnostic Testing of STDs Market: Key Takeaways
The Canadian market is mainly looking at the sale of unlicensed test kits through online distribution channels. To address this issue, clinical trials are needed to facilitate equipment approvals.
Key players in the market focus on approving and launching novel products to enlarge their product portfolio. For example, Chembio Diagnostics was approved by the WHO in November 2019, for a single-use immunochromatographic test to detect HIV self-test, HIV type 1 and 2 antibodies.
Global Diagnostic Testing of STDs Market: Key Developments
Key market players focus on approving and launching novel products to enlarge their product portfolio. For example, Binx Health received another 510 (k) clearance from the USFDA in April 2020, for Binx io, a nuclear point-of-care testing platform to detect chlamydia and gonorrhoea.
The key market players focused on adopting a collaborative strategy to enlarge their product portfolio. For example, Pinpoint Science Inc. partnered with Analog equiment, Inc. in February 2020 to develop and manufacture novel Nano sensor diagnostics for infectious disorders.
Global Diagnostic Testing of STDs Market: Segmentation
On the basis of Test Type, the Global Diagnostic Testing of STDs Market is segmented into:
- HPV+pap smear
On the basis of Region, the Global Diagnostic Testing of STDs Market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Global Diagnostic Testing of STDs Market: Competitive Landscape
Key players performing in the global diagnostic testing of STDs market are bioLytical Laboratories, Pinpoint Science Inc., Chembio Diagnostics, binx health, Hologic Inc., Danaher Corporation (Beckman Coulter), bioMerieux, Becton Dickinson & Company, Alere Inc., Roche Holdings AG, and Vela Diagnostics USA Inc.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/3917
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027